Advanced search
Publication Cover
Melanoma Management Volume 3, 2016 - Issue 4
Submit an article Journal homepage
43
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Vaccine Therapy + Dasatinib for the Treatment of Patients with Stage IIIB–IV Melanoma

Ahmad A Tarhini1 Department of Medicine,University of Pittsburgh School of Medicine,Pittsburgh,PA15213,USA;2 Melanoma Program of the University of Pittsburgh Cancer Institute,Pittsburgh,PA15213,USAView further author information
,
Hussein Tawbi3 Department of Melanoma Medical Oncology,University of Texas MD Anderson Cancer Center,Houston,TX77030,USAView further author information
&
Walter J Storkus2 Melanoma Program of the University of Pittsburgh Cancer Institute,Pittsburgh,PA15213,USA;4 Department of Dermatology,University of Pittsburgh School of Medicine,Pittsburgh,PA15213,USA;5 Department of Immunology,University of Pittsburgh School of Medicine,Pittsburgh,PA15213,USA;6 Department of Pathology,University of Pittsburgh School of Medicine,Pittsburgh,PA15213,USA;7 Department of Bioengineering,University of Pittsburgh School of Medicine,Pittsburgh,PA15213,USACorrespondence[email protected]
View further author information
Pages 251-254 | Received 15 May 2016, Accepted 03 Jun 2016, Published online: 29 Nov 2016
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Financial & competing interests disclosure

This work was supported by NIH R01 CA169118 (WJ Storkus) and the University of Pittsburgh Melanoma and Skin Cancer Specialized Programs of Research Excellence (SPORE) NIH P50 CA121973 (A Tarhini, WJ Storkus). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This work was supported by NIH R01 CA169118 (WJ Storkus) and the University of Pittsburgh Melanoma and Skin Cancer Specialized Programs of Research Excellence (SPORE) NIH P50 CA121973 (A Tarhini, WJ Storkus). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later
PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.